Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Hoffman

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The American Review of Respiratory Disease|May 1, 1992
Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factorP Q Eichacker, A Farese, W D Hoffman, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1993
Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shockP Q Eichacker, W D Hoffman, A Farese, et al.
The Journal of Infectious Diseases|March 1, 1994
Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharideW D Hoffman, M Pollack, S M Banks, et al.
Transfusion|March 1, 1993
Plasma exchange does not improve survival in a canine model of human septic shockC Natanson, W D Hoffman, L A Koev, et al.
The American Journal of Physiology|April 1, 1995
Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogsJ P Cobb, C Natanson, Z M Quezado, et al.
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
The Journal of Experimental Medicine|October 1, 1992
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxinJ P Cobb, C Natanson, W D Hoffman, et al.
JAMA|May 5, 1993
A controlled trial of HA-1A in a canine model of gram-negative septic shockZ M Quezado, C Natanson, D W Alling, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The American Review of Respiratory Disease|May 1, 1992
Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factorP Q Eichacker, A Farese, W D Hoffman, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 1, 1993
Leukocyte CD18 monoclonal antibody worsens endotoxemia and cardiovascular injury in canines with septic shockP Q Eichacker, W D Hoffman, A Farese, et al.
The Journal of Infectious Diseases|March 1, 1994
Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O polysaccharide and core regions of Escherichia coli lipopolysaccharideW D Hoffman, M Pollack, S M Banks, et al.
Transfusion|March 1, 1993
Plasma exchange does not improve survival in a canine model of human septic shockC Natanson, W D Hoffman, L A Koev, et al.
The American Journal of Physiology|April 1, 1995
Differential hemodynamic effects of L-NMMA in endotoxemic and normal dogsJ P Cobb, C Natanson, Z M Quezado, et al.
The Journal of Experimental Medicine|March 1, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shockC Natanson, P W Eichenholz, R L Danner, et al.
The Journal of Infectious Diseases|February 1, 1993
Therapeutic trial of lipid X in a canine model of septic shockR L Danner, P Q Eichacker, M E Doerfler, et al.
The Journal of Experimental Medicine|October 1, 1992
N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxinJ P Cobb, C Natanson, W D Hoffman, et al.
JAMA|May 5, 1993
A controlled trial of HA-1A in a canine model of gram-negative septic shockZ M Quezado, C Natanson, D W Alling, et al.
Pageof 4